DPP-4 inhibitors and angioedema: a cause for concern?

被引:16
|
作者
Byrd, Jennifer S. [2 ]
Minor, Deborah S. [1 ]
Elsayed, Raghda [3 ]
Marshall, Gallen D.
机构
[1] Univ Mississippi, Med Ctr, Dept Med, Div Gen Internal Med Hypertens, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Dept Pharm, Jackson, MS 39216 USA
[3] Providence Med Grp, Portland, OR USA
关键词
DIPEPTIDYL PEPTIDASE-IV; RISK; SITAGLIPTIN; BRADYKININ; EFFICACY; EDEMA;
D O I
10.1016/j.anai.2011.02.012
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:436 / 438
页数:3
相关论文
共 50 条
  • [21] The effects of DPP-4 inhibitors in human macrophages
    Benetti, E.
    Bordano, V.
    Boscaro, V.
    Cannito, S.
    Altamura, V.
    Barberis, M.
    Rosa, A.
    Bocca, C.
    Klein, T.
    Dianzani, C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S276 - S277
  • [22] An assessment of the potential toxicity of DPP-4 Inhibitors
    Russell, Jason L.
    Casavant, Marcel J.
    Spiller, Henry A.
    Mercurio-Zappala, Maria
    Huffman, R. Michelle
    CLINICAL TOXICOLOGY, 2013, 51 (07) : 657 - 657
  • [23] Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
    Subrahmanyan, Nikhila A.
    Koshy, Rithika M.
    Jacob, Koshy
    Pappachan, Joseph M.
    CURRENT DRUG SAFETY, 2021, 16 (02) : 154 - 164
  • [24] DPP-4 Inhibitors: The Seinfeld of Oral Antihyperglycemics
    Barry, Arden R.
    Turgeon, Ricky D.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2016, 69 (03): : 253 - 254
  • [25] Exploration of the DPP-4 inhibitors with a focus on saxagliptin
    Shubrook, Jay H.
    Colucci, Randall A.
    Schwartz, Frank L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (17) : 2927 - 2934
  • [28] THE ROLE OF DPP-4 INHIBITORS IN ANGIOGENESIS IN DIABETES
    Chan, Jenq-Shyong
    Wu, Tao-Cheng
    Chen, Jaw-Wen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 171 - 172
  • [30] Novel DPP-4 inhibitors against diabetes
    Liu, Yang
    Hu, Yongzhou
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (07) : 793 - 808